By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366


SEARCH JOBS


Industry
Healthcare






Company News
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc. (GILD)'s Harvoni™ (ledipasvir/sofosbuvir), The First Once-Daily Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C 10/17/2014 7:14:37 AM
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014 8:09:17 AM
Novartis AG (NVS) Release: (Pr)Lucentis® (ranibizumab) Approved By Health Canada To Treat Vision Loss Resulting From Choroidal Neovascularization In Pathologic Myopia (mCNV)(1) 10/8/2014 7:50:42 AM
Helius Medical Technologies Announces Health Canada Approval To Start Investigational Testing For The Pons™ Device 10/2/2014 10:36:58 AM
Health Canada Release: Statement By The Honourable Rona Ambrose On The Import Ban Of Drug Products From Three Plants In India 10/1/2014 8:02:13 AM
Information Update - Health Canada Takes Action To Stop Import Of Products From Three Sites In India 10/1/2014 8:01:01 AM
Health Canada Release: Government Of Canada Takes Action To Protect Youth From The Dangers Of Tobacco Use 9/30/2014 7:59:20 AM
Medunik Canada Announces Health Canada Priority Review Of PHEBURANE© Indicated For The Treatment Of Urea Cycle Disorders (UCD) 9/25/2014 8:50:45 AM
Information Update - Health Canada Requests Quarantine Of Products For Canadian Market From Apotex Inc. Facility In Bangalore, India 9/25/2014 7:48:02 AM
Medunik Canada Announces Health Canada Priority Review Of PHEBURANE® Indicated For The Treatment Of Urea Cycle Disorders (UCD) 9/24/2014 9:10:38 AM
12345678910...
//-->